About Gensynth Laboratories
Gensynth Laboratories is a company based in Hyderabad (India). It operates as a B2B. The company has 83 employees as of March 31, 2023. Gensynth Laboratories offers products and services including Methyl-1-[(2-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate, Methyl-2-ethoxy-1-[[2’-(1h-tetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate, and 2-Ethoxy-1[(2'(1-triphenylmethyl) 1H-tetrazol-5yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid. Gensynth Laboratories operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 83 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Gensynth Laboratories Private Limited
- Date of Incorporation 23 Dec, 2004
- Jurisdiction Patancheru, Telangana, India
-
Annual Revenue
$5.32 M (USD)35.25as on Mar 31, 2023
-
Net Profit
$24.91 K (USD)26.57as on Mar 31, 2023
-
EBITDA
$1.76 M (USD)1260.62as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
83
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gensynth Laboratories
Gensynth Laboratories offers a comprehensive portfolio of products and services, including Methyl-1-[(2-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate, Methyl-2-ethoxy-1-[[2’-(1h-tetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate, and 2-Ethoxy-1[(2'(1-triphenylmethyl) 1H-tetrazol-5yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid.
Used as intermediate for producing Candesartan Cilexetil API.
Serves as key component in Candesartan Cilexetil synthesis.
Intermediate for Candesartan Cilexetil manufacturing process.
Funding Insights of Gensynth Laboratories
Detailed funding history for Gensynth Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gensynth Laboratories
Investment portfolio details for Gensynth Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gensynth Laboratories
Detailed financials for Gensynth Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gensynth Laboratories Comparisons
Peer comparison for Gensynth Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gensynth Laboratories
Gensynth Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| Locked | Locked | Locked |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| Locked | Locked | Locked |
Advanced API intermediates are manufactured for pharmaceutical use.
|
|
| Locked | Locked | Locked |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing of APIs and intermediates
|
Detailed competitors of Gensynth Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gensynth Laboratories
Complete news archive for Gensynth Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gensynth Laboratories
Gensynth Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Gensynth Laboratories is 83.
Annual revenue of Gensynth Laboratories is $5.32M as on Mar 31, 2023.
Gensynth Laboratories Pvt. Ltd is a USFDA site approved manufacturer of advanced pharmaceutical intermediates, focusing on expanding product portfolios and providing cost-effective solutions. Located in Pashamylaram near Hyderabad, India, the company operates a fully equipped RD center to support innovation in the pharmaceutical sector. They engage in producing intermediates for APIs like Candesartan Cilexetil, targeting the broader pharmaceutical market without specifying particular clients.
Gensynth Laboratories's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Gensynth Laboratories offers Methyl-1-[(2-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate, Methyl-2-ethoxy-1-[[2’-(1h-tetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate, and 2-Ethoxy-1[(2'(1-triphenylmethyl) 1H-tetrazol-5yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid.